Cannabis investors face a red day with pot stocks taking hits on Thursday (September 27) after the Ontario provincial government outlined its decision to restrict LPs to one retail license in the province.

Ontario’s Attorney General Caroline Mulroney stated during a press conference there would be no limit on the total amount of licenses given out to Canadian LPs, but would instead be given the chance to apply for a “single retail operator license” only.


“Any licensed producer will be permitted to hold a single retail license at a single production site located in Ontario,” Mulroney said. The province will also limit how many licenses a specific company or person may hold.

The new Ontario plan will see the installation of these shops by April of next year.

Canadian LP Canopy Growth (NYSE:CGC,TSX:WEED), issued a response on Thursday to the Ontario legislation.

The company hinted to shareholders it still plans to pursue “additional retail capabilities” through the Tokyo Smoke platform and potential investments from Canopy Rivers (TSXV:RIV).

When it comes to Ontario, the producer will seek its single retail license for its headquarters in Smith Falls.

Allan Rewak, executive director of The Cannabis Council of Canada, an association representing the interests of Canadian LPs, told the Investing News Network (INN) the council is “eagerly awaiting the introduction of legislation” in order to better understand how exactly the government is planning its approach.

The council had previously issued a warm response to the new Ontario retail framework implemented by Premier Doug Ford.

Frank Robinson, a partner in the franchise law group at Cassels Brock, said the new regulations will “shut out” the big producers and create opportunities for franchising by LPs.

“The only way [LPs] will be able to get their logos and brands on storefronts is to license or franchise all of these small business people to which the province wants to allow access,” Robinson said.

“This sets the stage for a varied and comprehensive cannabis retail experience, which should be expected to include the use of franchise systems, helping operators market faster, harness established operating systems, create quality and brand reliability and keep shelves stocked.”

Market reaction

The Horizons Marijuana Life Science Index ETF (TSX:HMMJ), which added nine new stocks into its holdings on Wednesday (September 26) and the Evolve Marijuana ETF (TSX:SEED) both declined in value on Thursday’s trading session.

As of 12:30 p.m. EST, HMMJ and SEED saw drops of 0.99 and 2.37 percent respectively. HMMJ holds a price of C$23.98 and SEED is valued at C$23.90.

Another indicator of the overall Canadian market is the Marijuana Index from The Arcview Group. On Tuesday (September 25), the index showed all but one of its 17 constituents with a loss. The overall index was down 31.19 percent in value.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less